Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Corcept Therapeutics (CORT) Receivables - Net (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Receivables - Net for 15 consecutive years, with $39.1 million as the latest value for Q1 2026.

  • For Q1 2026, Receivables - Net fell 36.8% year-over-year to $39.1 million; the TTM value through Mar 2026 reached $39.1 million, down 36.8%, while the annual FY2025 figure was $59.8 million, 10.76% up from the prior year.
  • Receivables - Net hit $39.1 million in Q1 2026 for Corcept Therapeutics, down from $59.8 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $69.6 million in Q3 2025 and bottomed at $27.2 million in Q1 2022.
  • Average Receivables - Net over 5 years is $45.9 million, with a median of $41.1 million recorded in 2023.
  • Year-over-year, Receivables - Net soared 88.95% in 2024 and then crashed 36.8% in 2026.
  • Corcept Therapeutics' Receivables - Net stood at $31.1 million in 2022, then soared by 32.41% to $41.1 million in 2023, then skyrocketed by 31.26% to $54.0 million in 2024, then rose by 10.76% to $59.8 million in 2025, then tumbled by 34.65% to $39.1 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $39.1 million, $59.8 million, and $69.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.